Hyperprogressive Disease during Anti-PD-1 (PDCD1) / PD-L1 (CD274) Therapy: A Systematic Review and Meta-Analysis

Hyperprogressive Disease during Anti-PD-1 (PDCD1) / PD-L1 (CD274) Therapy: A Systematic Review and Meta-Analysis

Hyperprogressive disease (HPD) is a recently acknowledged pattern of rapid tumor progression after the initiation of immune checkpoint inhibitors. HPD has been observed across various types of tumors and has been associated with poor survival. We performed a meta-analysis to identify baseline (i.e.,...

Full description

Bibliographic Details
Main Authors: Jong Yeob Kim, Keum Hwa Lee, Jeonghyun Kang, Edith Borcoman, Esma Saada-Bouzid, Andreas Kronbichler, Sung Hwi Hong, Leandro Fórnias Machado de Rezende, Shuji Ogino, Nana Keum, Mingyang Song, Claudio Luchini, Hans J. van der Vliet, Jae Il Shin, Gabriele Gamerith
Format: Article
Language:English
Published: MDPI AG 2019-11-01
Series:Cancers
Subjects:
immunotherapy
hyperprogression
hyper-progressive disease
Online Access:https://www.mdpi.com/2072-6694/11/11/1699

Internet

https://www.mdpi.com/2072-6694/11/11/1699

Similar Items